A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping

Clinical trial NCT02509598 · COMPLETED

Trial details

NCT number: NCT02509598
Sponsor: Cardinal Health 414, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rhabdomyosarcoma Melanoma

Start date: 2015-08-01
Primary completion: 2019-03-06
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.